C4ORF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.214400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.817400E-01
Normal-vs-Stage2
7.358000E-01
Normal-vs-Stage3
4.494800E-01
Normal-vs-Stage4
6.292600E-01
Stage1-vs-Stage2
9.765000E-01
Stage1-vs-Stage3
4.821600E-01
Stage1-vs-Stage4
3.064400E-01
Stage2-vs-Stage3
4.445200E-01
Stage2-vs-Stage4
2.282000E-01
Stage3-vs-Stage4
2.473200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.074200E-01
Normal-vs-AfricanAmerican
8.431800E-01
Normal-vs-Asian
5.204200E-01
Caucasian-vs-AfricanAmerican
8.820600E-01
Caucasian-vs-Asian
4.298800E-01
AfricanAmerican-vs-Asian
5.980400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.135800E-01
Normal-vs-Female
8.804800E-01
Male-vs-Female
1.544570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.974200E-01
Normal-vs-Age(41-60Yrs)
6.916000E-01
Normal-vs-Age(61-80Yrs)
4.583600E-01
Normal-vs-Age(81-100Yrs)
3.968800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.663200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.429200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.542000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.95270000000237E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.934100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.977600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.733200E-01
Normal-vs-Daily Drinker
5.104600E-01
Normal-vs-Weekly Drinker
2.973600E-01
Normal-vs-Occasional Drinker
9.176600E-01
Normal-vs-Social Drinker
9.233600E-01
Non Drinker-vs-Daily Drinker
9.250000E-01
Non Drinker-vs-Weekly Drinker
5.882400E-01
Non Drinker-vs-Occasional Drinker
1.771750E-01
Non Drinker-vs-Social Drinker
3.508200E-01
Daily Drinker-vs-Weekly Drinker
4.728800E-01
Daily Drinker-vs-Occasional Drinker
1.678210E-01
Daily Drinker-vs-Social Drinker
3.393800E-01
Weekly Drinker-vs-Occasional Drinker
6.950100E-02
Weekly Drinker-vs-Social Drinker
1.435990E-01
Occasional Drinker-vs-Social Drinker
7.252800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.294100E-02
Normal-vs-Grade 2
4.242900E-03
Normal-vs-Grade 3
2.254400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.764000E-02
Grade 1-vs-Grade 3
1.143350E-01
Grade 1-vs-Grade 4
6.294100E-02
Grade 2-vs-Grade 3
9.608200E-01
Grade 2-vs-Grade 4
4.242900E-03
Grade 3-vs-Grade 4
2.254400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.247000E-01
Normal-vs-NonDiabetic
6.721200E-01
Diabetic-vs-NonDiabetic
8.358600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.638400E-01
Normal-vs-NoPancreatitis
6.793600E-01
Pancreatitis-vs-NoPancreatitis
9.712000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.371400E-01
Normal-vs-N1
7.843000E-01
N0-vs-N1
4.813200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.866400E-01
Normal-vs-TP53-NonMutant
3.936800E-01
TP53-Mutant-vs-TP53-NonMutant
2.836000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
